Valuation: NeuroPace, Inc.

Market Cap 429M 385M 352M 321M 605M 40.33B 624M 4.24B 1.69B 21.52B 1.61B 1.58B 67.94B P/E 2026 *
-24.4x
P/E 2027 * -47.9x
Enterprise Value 452M 406M 371M 338M 638M 42.51B 658M 4.47B 1.78B 22.68B 1.7B 1.66B 71.61B EV / Sales 2026 *
4.51x
EV / Sales 2027 * 3.63x
Free-Float
82.62%
Yield 2026 *
-
Yield 2027 * -
1 day-1.50%
1 week+1.63%
Current month+1.63%
1 month-1.34%
3 months-10.07%
6 months-31.02%
Current year-19.04%
1 week 12
Extreme 12
13.94
1 month 12
Extreme 12
13.94
Current year 12
Extreme 12
19.6
1 year 12
Extreme 12
19.6
3 years 5.45
Extreme 5.45
19.6
5 years 1.22
Extreme 1.22
19.6
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 10/07/2023
Director of Finance/CFO 53 20/06/2025
Chief Operating Officer 48 01/05/2024
Director TitleAgeSince
Director/Board Member 57 01/01/2013
Chairman 84 01/12/1997
Director/Board Member 46 01/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
24/09/26 Tax

Chief Technology Officer

-335 0.0010%
20/09/26 Tax

Chief Financial Officer

-1,162 0.0034%
03/09/26 Tax

Chief Executive Officer

-1,310 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+1.63%-2.19%+73.61% 429M
+2.63%-0.32%+22.75%+52.69% 257B
-3.36%+4.81%-17.34%+63.31% 157B
+1.73%-0.85%+9.29%+17.76% 162B
-4.23%+1.83%-56.84%-19.05% 61.96B
+1.31%+11.01%+23.90%+52.22% 58.73B
-0.76%+4.13%+0.84%-6.12% 55.42B
-2.05%-2.95%+4.30%+54.85% 49.18B
+1.73%-0.06%+18.49%+62.52% 49.27B
+1.00%-1.11%+23.29%+81.48% 44.96B
Average -0.35%+1.39%+2.65%+43.33% 89.63B
Weighted average by Cap. +0.26%+1.20%+5.29%+41.72%

Financials

2026 *2027 *
Net sales 100M 90M 82.25M 75.08M 141M 9.43B 146M 991M 395M 5.03B 377M 369M 15.89B 122M 110M 100M 91.64M 173M 11.51B 178M 1.21B 483M 6.14B 460M 450M 19.39B
Net income -18.06M -16.2M -14.8M -13.51M -25.46M -1.7B -26.26M -178M -71.16M -906M -67.79M -66.34M -2.86B -8.98M -8.05M -7.36M -6.72M -12.66M -844M -13.06M -88.72M -35.38M -450M -33.7M -32.98M -1.42B
Net Debt 23.21M 20.82M 19.03M 17.37M 32.72M 2.18B 33.75M 229M 91.45M 1.16B 87.13M 85.26M 3.68B 16.02M 14.37M 13.13M 11.99M 22.58M 1.51B 23.29M 158M 63.11M 803M 60.12M 58.84M 2.54B
Projected Income Statement - Annual - NeuroPace, Inc.
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
06/11/26 $12.50 -1.50% 128,446
05/11/26 $12.69 -4.87% 122,031
04/11/26 $13.34 +8.37% 227,881
03/11/26 $12.31 -0.24% 199,830
02/11/26 $12.34 +0.33% 120,460
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - NeuroPace, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
12.50USD
Average target price
20.00USD
Spread / Average Target
+60.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - NeuroPace, Inc.
  1. Stock Market
  2. Stocks
  3. NPCE Stock